Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.42B P/E - EPS this Y 8.30% Ern Qtrly Grth -
Income -54.37M Forward P/E 23.52 EPS next Y 17.30% 50D Avg Chg 3.00%
Sales 1.71B PEG 1.00 EPS past 5Y -20.56% 200D Avg Chg 11.00%
Dividend N/A Price/Book 0.99 EPS next 5Y 21.10% 52W High Chg -6.00%
Recommedations 1.70 Quick Ratio 0.89 Shares Outstanding 54.84M 52W Low Chg 43.00%
Insider Own 5.73% ROA -0.11% Shares Float 49.64M Beta 2.07
Inst Own 107.15% ROE -1.57% Shares Shorted/Prior 4.17M/4.14M Price 62.81
Gross Margin 58.20% Profit Margin -1.95% Avg. Volume 410,093 Target Price 75.20
Oper. Margin 2.81% Earnings Date May 2 Volume 384,268 Change -1.44%
About Enovis Corporation

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Enovis Corporation News
04/25/24 20 Fastest Growing Health Tech Companies in the World
04/17/24 Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
03/28/24 Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
02/23/24 Enovis Corporation (NYSE:ENOV) Q4 2023 Earnings Call Transcript
02/22/24 Q4 2023 Enovis Corp Earnings Call
02/22/24 Enovis Corp (ENOV) Reports Solid Growth in Q4 and Full Year 2023 Earnings
02/22/24 Enovis Announces Fourth Quarter and Full Year 2023 Results
02/20/24 Biotricity Inc. (BTCY) Reports Q3 Loss, Misses Revenue Estimates
02/12/24 Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
02/07/24 Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
02/06/24 GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Surpass Estimates
01/29/24 Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
01/26/24 Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
01/25/24 Enovis Introduces the DonJoy ROAM™ OA Knee Brace
01/04/24 Enovis (ENOV) to Strengthen Portfolio Via Its Latest Buyout
01/03/24 Why Community Health (CYH) Shares Are Attracting Investors Now
01/03/24 Enovis Completes Acquisition of LimaCorporate S.p.A
01/02/24 Ensign (ENSG) Buys 2 Nursing Facilities in Tennessee & Nevada
12/28/23 Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
12/17/23 Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)
ENOV Chatroom

User Image Stock_Titan Posted - 1 week ago

$ENOV Enovis to Host First Quarter 2024 Results Conference Call on May 2nd https://www.stocktitan.net/news/ENOV/enovis-to-host-first-quarter-2024-results-conference-call-on-may-emt03qxdveok.html

User Image Stock_Titan Posted - 03/28/24

$ENOV Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/ENOV/enovis-to-participate-in-the-23rd-annual-needham-virtual-healthcare-45cvkxqe2wfh.html

User Image TickerDD_com Posted - 1 month ago

From 3/8/2024, looking back across 22 Month-Ends for ENOV, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had More Positives (95%) $ENOV #ENOV #ENOVStock #TickerDD https://www.youtube.com/watch?v=V9Upt91XGh4

User Image swingingtech Posted - 02/28/24

$VLTO $DHR $ENOV $ESAB https://wallstreetwaves.com/veralto-the-unassuming-esg-powerhouse-that-will-likely-double/

User Image AnaChart Posted - 2 months ago

$ENOV https://anachart.com/wp-content/uploads/ana_temp/1708682578_soc-img.jpg

User Image DonCorleone77 Posted - 2 months ago

$ENOV Enovis files automatic mixed securities shelf

User Image Estimize Posted - 2 months ago

$ENOV beats the Estimize EPS Consensus by 3c and the Estimize Revenue Consensus by $5.60M. Reports FQ4 earnings of 79c EPS and $455.02M... http://www.estimize.com/enov/fq4-2023?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image DonCorleone77 Posted - 2 months ago

$ENOV Enovis sees 2024 adjusted EPS $2.50-$2.65, consensus $2.70 Sees 2024 revenue $2.05B-2.15B, consensus $2.02B.

User Image DonCorleone77 Posted - 2 months ago

$ENOV Enovis reports Q4 adjusted EPS 79c, consensus 74c Reports Q4 revenue $455M, consensus $445.36M. "We are very pleased with our results in 2023 with both revenues and operating margins exceeding expectations while continuing to make investments in key growth initiatives and M&A," said Matt Trerotola, CEO. "We look forward to carrying this momentum into 2024, which is setting up to be a transformative year as we integrate Lima and kick off a multi-year cadence of new product introductions across Recon and P&R."

User Image Stock_Titan Posted - 2 months ago

$ENOV Enovis Announces Fourth Quarter and Full Year 2023 Results https://www.stocktitan.net/news/ENOV/enovis-announces-fourth-quarter-and-full-year-2023-3ynuxmr6hrck.html

User Image Estimize Posted - 2 months ago

$ENOV reports before the open tomorrow, Estimize Consensus +0.02 EPS and +4.18M Revs compared to WS http://www.estimize.com/enov/fq4-2023?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image Stock_Titan Posted - 2 months ago

$ENOV Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting https://www.stocktitan.net/news/ENOV/enovis-to-highlight-latest-technologies-across-the-orthopedic-care-fo2c0cafogng.html

User Image Stock_Titan Posted - 2 months ago

$ENOV Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024 https://www.stocktitan.net/news/ENOV/enovis-to-present-at-the-canaccord-genuity-musculoskeletal-tg6h0kurj9yu.html

User Image erevnon Posted - 3 months ago

UBS initiates coverage on Enovis $ENOV at Buy rating and a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image tickeron Posted - 3 months ago

If you’re trading this week, Read This! $ENOV MACD Histogram turned positive on January 19, 2024. View odds of downtrend. https://srnk.us/go/4974648

User Image StockAutomatePro Posted - 3 months ago

$ENOV The chart is pointing towards a potential boom in the stock. We alerted the BUY signal at $57.65 and we were able to close this one with profit at $59.84 🎯

User Image StockAutomatePro Posted - 3 months ago

$ENOV The chart is indicating an upward trajectory for the stock price We alerted the BUY signal at $55.6 and we were able to close this one with profit at $58.17 🔏

User Image StockAutomatePro Posted - 3 months ago

$ENOV Chart analysis suggests a bullish outlook for the stock. We alerted the BUY signal at $55.64 and we were able to close this one with profit at $58.46 ✅

User Image tickeron Posted - 3 months ago

This is amazing! What do you think? $ENOV MACD Histogram turned positive on January 9, 2024. View odds of downtrend. https://srnk.us/go/4965169

User Image StockAutomatePro Posted - 3 months ago

$ENOV Chart is suggesting a bullish trend for the stock. We alerted the BUY signal at $56.12 and we were able to close this one with profit at $58.02🤙 See more details at StockAutomate.com

User Image Last10K Posted - 3 months ago

$ENOV just filed with the SEC a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/ENOV/0001193125-24-003983.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ENOV

User Image risenhoover Posted - 3 months ago

$ENOV / Enovis files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 Enovis Corporatio https://fintel.io/doc/sec-enovis-corp-1420800-8k-2024-january-08-19730-5069?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Stock_Titan Posted - 3 months ago

$OFIX $ENOV Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer https://www.stocktitan.net/news/OFIX/orthofix-provides-executive-management-business-update-and-appoints-9i5p07xsm4u0.html

User Image Last10K Posted - 3 months ago

$ENOV just filed with the SEC a Change in Assets, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/ENOV/0001193125-24-000976.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ENOV

User Image risenhoover Posted - 3 months ago

$ENOV / Enovis files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2024 Enovis Corporatio https://fintel.io/doc/sec-enovis-corp-1420800-8k-2024-january-03-19725-4217?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Stock_Titan Posted - 3 months ago

$ENOV Enovis Completes Acquisition of LimaCorporate S.p.A https://www.stocktitan.net/news/ENOV/enovis-completes-acquisition-of-lima-corporate-s-p-4uei9n2i26jj.html

User Image Stock_Titan Posted - 12/28/23

$ENOV Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference https://www.stocktitan.net/news/ENOV/enovis-to-participate-in-the-42nd-annual-j-p-morgan-healthcare-aq6iurrmne7f.html

User Image StockAutomatePro Posted - 4 months ago

$ENOV The chart is predicting a profitable future for the stock. We alerted the BUY signal at $50 and we were able to close this one with profit at $55.57 💯

User Image DonCorleone77 Posted - 4 months ago

$ENOV $BSX Enovis named 2024 Top Pick, added to Conviction List at Needham Needham raised the firm's price target on Enovis (ENOV) to $70 from $62 and keeps a Buy rating on the shares. The analyst is also adding the stock to the firm's Conviction List in place of Boston Scientific (BSX), while naming Enovis a Top Pick for 2024. Needham is citing its confidence in the company's revenue growth and margin drivers and anticipates multiple significant top and bottom line growth drivers in 2024, including the EMPOWR Revision launch, the ARVIS 2.0 launch, and the Lima acquisition that is expected to close in early 2024.

User Image MarketBeat Posted - 4 months ago

Enovis's PT raised by Needham & Company LLC to $70.00. buy rating. www.marketbeat.com/stocks/NYSE/ENOV/price-target/ $ENOV

Analyst Ratings
Needham Buy Apr 10, 24
Wells Fargo Overweight Feb 23, 24
Canaccord Genuity Buy Feb 23, 24
Needham Buy Feb 23, 24
Stephens & Co. Overweight Feb 13, 24
UBS Buy Jan 22, 24
Needham Buy Jan 8, 24
William Blair Outperform Jan 3, 24
Canaccord Genuity Buy Dec 20, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
KLECKNER JOHN Principal Accounting.. Principal Accounting Officer Aug 07 Sell 59.18 174 10,297 4,218 08/07/23
KLECKNER JOHN Principal Accounting.. Principal Accounting Officer Jul 20 Sell 65.32 67 4,376 4,392 07/20/23
BERRY PHILLIP BENJAMIN (BEN) SVP, Chief Financial.. SVP, Chief Financial Officer Jun 02 Sell 54.17 645 34,940 20,223 06/02/23
Vinnakota Rajiv Director Director May 08 Sell 57.18 1,396 79,823 11,901 05/09/23
Vinnakota Rajiv Director Director May 08 Option 42.43 1,396 59,232 13,297 05/09/23
BERRY PHILLIP BENJAMIN (BEN) SVP, Chief Financial.. SVP, Chief Financial Officer Mar 20 Sell 51.84 600 31,104 20,868 03/21/23
PERFALL A CLAYTON Director Director Mar 16 Sell 52.13 2,793 145,599 32,033 03/20/23
PERFALL A CLAYTON Director Director Mar 16 Option 42.43 2,793 118,507 34,826 03/20/23
PRYOR DANIEL A EVP, Strategy & Busi.. EVP, Strategy & Business Dev. Feb 27 Sell 56.08 5,716 320,553 78,137 03/01/23
Tandy Bradley J SVP, General Counsel SVP, General Counsel Feb 27 Sell 56.08 2,491 139,695 13,483 03/01/23
Shirley Brady Pres. & COO Pres. & COO Feb 21 Sell 58.37 2,722 158,883 46,733 02/23/23
Lang Patricia A SVP, Chief HR Office.. SVP, Chief HR Officer Feb 21 Sell 58.36 985 57,485 14,416 02/23/23
Trerotola Matthew L. President & CEO President & CEO Feb 21 Sell 58.37 7,725 450,908 162,544 02/23/23
BERRY PHILLIP BENJAMIN (BEN) SVP, Chief Financial.. SVP, Chief Financial Officer Feb 21 Sell 58.37 539 31,461 16,630 02/23/23
PRYOR DANIEL A EVP, Strategy & Busi.. EVP, Strategy & Business Dev. Feb 21 Sell 58.36 2,219 129,501 73,512 02/23/23
Tandy Bradley J SVP, General Counsel SVP, General Counsel Feb 21 Sell 58.27 1,224 71,322 12,621 02/23/23
KLECKNER JOHN Principal Accounting.. Principal Accounting Officer Feb 21 Sell 61.45 134 8,234 2,342 02/23/23
Hix Christopher M EVP, Chief Financial.. EVP, Chief Financial Officer Dec 14 Sell 55.28 1,367 75,568 44,605 12/15/22
Tandy Bradley J SVP, General Counsel SVP, General Counsel Aug 08 Sell 58.39 3,355 195,898 13,845 08/10/22
KLECKNER JOHN Principal Accounting.. Principal Accounting Officer Jul 20 Sell 56.729 44 2,496 1,661 07/21/22
Shirley Brady EVP, Colfax, Pres. &.. EVP, Colfax, Pres. & CEO, DJO Mar 07 Sell 38.88 3,624 140,901 102,326 03/09/22
Trerotola Matthew L. President & CEO President & CEO Mar 07 Sell 38.88 12,002 466,638 413,524 03/09/22
Tandy Bradley J SVP, General Counsel SVP, General Counsel Mar 07 Sell 38.88 1,498 58,242 22,361 03/09/22
Lang Patricia A SVP, Chief HR Office.. SVP, Chief HR Officer Mar 07 Sell 38.88 1,425 55,404 33,105 03/09/22
Kambeyanda Shyam ESAB President and E.. ESAB President and EVP, Colfax Mar 07 Sell 38.88 2,788 108,397 100,985 03/09/22
PRYOR DANIEL A EVP, Strategy & Busi.. EVP, Strategy & Business Dev. Mar 07 Sell 38.88 3,463 134,641 200,175 03/09/22
Hix Christopher M EVP, Chief Financial.. EVP, Chief Financial Officer Mar 01 Sell 39.52 1,800 71,136 143,417 03/03/22
Lang Patricia A SVP, Chief HR Office.. SVP, Chief HR Officer Mar 01 Sell 39.52 379 14,978 34,530 03/03/22
Tandy Bradley J SVP, General Counsel SVP, General Counsel Feb 25 Sell 42.18 656 27,670 23,859 03/01/22
Trerotola Matthew L. President & CEO President & CEO Feb 25 Sell 41.07 99,068 4,068,723 425,526 03/01/22
PRYOR DANIEL A EVP, Strategy & Busi.. EVP, Strategy & Business Dev. Feb 25 Sell 41.68 33,298 1,387,861 203,638 03/01/22
Shirley Brady EVP, Colfax, Pres. &.. EVP, Colfax, Pres. & CEO, DJO Feb 25 Sell 42.18 5,295 223,343 105,950 03/01/22
Kambeyanda Shyam ESAB President and E.. ESAB President and EVP, Colfax Feb 25 Sell 41.73 22,819 952,237 103,773 03/01/22
Hix Christopher M EVP, Chief Financial.. EVP, Chief Financial Officer Feb 25 Sell 41.3 33,286 1,374,712 145,217 03/01/22
Trerotola Matthew L. President & CEO President & CEO Feb 23 Sell 41.83 6,465 270,431 339,527 02/25/22
Tandy Bradley J SVP, General Counsel SVP, General Counsel Feb 23 Sell 41.83 807 33,757 24,515 02/25/22
Shirley Brady EVP, Colfax, Pres. &.. EVP, Colfax, Pres. & CEO, DJO Feb 23 Sell 41.83 2,002 83,744 111,245 02/25/22
PITTS DOUGLAS J. Controller, PAO Controller, PAO Feb 23 Sell 41.83 531 22,212 10,427 02/25/22
Kambeyanda Shyam ESAB President and E.. ESAB President and EVP, Colfax Feb 23 Sell 41.83 1,533 64,125 82,447 02/25/22
Lang Patricia A SVP, Chief HR Office.. SVP, Chief HR Officer Feb 23 Sell 41.83 851 35,597 23,703 02/25/22
Hix Christopher M EVP, Chief Financial.. EVP, Chief Financial Officer Feb 23 Sell 41.83 1,917 80,188 110,588 02/25/22
Trerotola Matthew L. President & CEO President & CEO Jun 23 Option 23.74 75,000 1,780,500 380,708 06/23/21
Trerotola Matthew L. President & CEO President & CEO Jun 23 Sell 44.41 75,000 3,330,750 305,708 06/23/21
Hix Christopher M EVP, Chief Financial.. EVP, Chief Financial Officer Jun 15 Option 26.56 90,000 2,390,400 182,800 06/15/21
Trerotola Matthew L. President & CEO President & CEO Jan 07 Sell 38.3 22,039 844,094 200,967 01/07/21